295 related articles for article (PubMed ID: 28837258)
1. Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.
Miyake M; Morizawa Y; Hori S; Tatsumi Y; Onishi S; Owari T; Iida K; Onishi K; Gotoh D; Nakai Y; Anai S; Chihara Y; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Fujimoto K
Cancer Sci; 2017 Nov; 108(11):2221-2228. PubMed ID: 28837258
[TBL] [Abstract][Full Text] [Related]
2. Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder.
Miyake M; Hori S; Morizawa Y; Tatsumi Y; Toritsuka M; Ohnishi S; Shimada K; Furuya H; Khadka VS; Deng Y; Ohnishi K; Iida K; Gotoh D; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Konishi N; Fujimoto K
Oncotarget; 2017 May; 8(22):36099-36114. PubMed ID: 28415608
[TBL] [Abstract][Full Text] [Related]
3. Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study.
Pichler R; Tulchiner G; Fritz J; Schaefer G; Horninger W; Heidegger I
Int J Med Sci; 2017; 14(9):811-819. PubMed ID: 28824318
[No Abstract] [Full Text] [Related]
4. Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer.
Liu C; Shi B; Hao C; Wang Q; Lv Q; Xing N; Shou J; Qu L; Gao Y; Qin C; Zhao J; Shou C
Oncotarget; 2016 Jul; 7(28):43432-43441. PubMed ID: 27223068
[TBL] [Abstract][Full Text] [Related]
5. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
[TBL] [Abstract][Full Text] [Related]
6. A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results.
Poulakis V; Witzsch U; De Vries R; Altmannsberger HM; Manyak MJ; Becht E
BJU Int; 2001 Nov; 88(7):692-701. PubMed ID: 11890239
[TBL] [Abstract][Full Text] [Related]
7. Standardization of assay for cytokeratin-related tumor marker CYFRA21.1 in urine samples.
Dittadi R; Barioli P; Gion M; Mione R; Barichello M; Capitanio G; Cocco G; Cazzolato G; De Biasi F; Praturlon S; Antinozzi R; Gianneo E
Clin Chem; 1996 Oct; 42(10):1634-8. PubMed ID: 8855147
[TBL] [Abstract][Full Text] [Related]
8. Urinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer.
Nitta Y; Konishi H; Makino T; Tanaka T; Kawashima H; Iovanna JL; Nakatani T; Kiyama H
BMC Urol; 2012 Sep; 12():24. PubMed ID: 22943287
[TBL] [Abstract][Full Text] [Related]
9. The follow-up of patients with non-muscle-invasive bladder cancer by urine cytology, abdominal ultrasound and urine CYFRA 21-1: a pilot study.
Nisman B; Yutkin V; Peretz T; Shapiro A; Barak V; Pode D
Anticancer Res; 2009 Oct; 29(10):4281-5. PubMed ID: 19846987
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer.
Abd El Gawad IA; Moussa HS; Nasr MI; El Gemae EH; Masooud AM; Ibrahim IK; El Hifnawy NM
J Egypt Natl Canc Inst; 2005 Sep; 17(3):193-202. PubMed ID: 16799657
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of AIB1 and EIF5A2 for noninvasive detection of bladder cancer in urine samples.
Zhou BF; Wei JH; Chen ZH; Dong P; Lai YR; Fang Y; Jiang HM; Lu J; Zhou FJ; Xie D; Luo JH; Chen W
Oncotarget; 2016 Jul; 7(27):41703-41714. PubMed ID: 27203388
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D
Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.
Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ
Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755
[TBL] [Abstract][Full Text] [Related]
14. NMP 22, BTA stat test and cytology in the diagnosis of bladder cancer: a comparative study.
Gutiérrez Baños JL; Rebollo Rodrigo MH; Antolín Juárez FM; Martín García B
Urol Int; 2001; 66(4):185-90. PubMed ID: 11385303
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.
Schmidt J; Propping C; Siow WY; Lohse-Fischer A; Toma M; Baldauf-Twelker A; Hakenberg OW; Wirth MP; Fuessel S
J Cancer Res Clin Oncol; 2016 Feb; 142(2):401-14. PubMed ID: 26328914
[TBL] [Abstract][Full Text] [Related]
16. BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder.
Casetta G; Gontero P; Zitella A; Pelucelli G; Formiconi A; Priolo G; Martinasso G; Mengozzi G; Aimo G; Viberti L; Tizzani A
Urol Int; 2000; 65(2):100-5. PubMed ID: 11025432
[TBL] [Abstract][Full Text] [Related]
17. CYFRA21-1 levels could be a biomarker for bladder cancer: a meta-analysis.
Kuang LI; Song WJ; Qing HM; Yan S; Song FL
Genet Mol Res; 2015 Apr; 14(2):3921-31. PubMed ID: 25966163
[TBL] [Abstract][Full Text] [Related]
18. Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors.
Smrkolj T; Mihelič M; Sedlar A; Sterle I; Osredkar J; Sedmak B
Clin Chem Lab Med; 2011 Feb; 49(2):311-6. PubMed ID: 21118051
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic values of urine CYFRA21-1, NMP22, UBC, and FDP for the detection of bladder cancer.
Jeong S; Park Y; Cho Y; Kim YR; Kim HS
Clin Chim Acta; 2012 Dec; 414():93-100. PubMed ID: 22944145
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer.
Landman J; Chang Y; Kavaler E; Droller MJ; Liu BC
Urology; 1998 Sep; 52(3):398-402. PubMed ID: 9730450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
